Skip to main content
Top

25-09-2023 | Bronchial Asthma | News

ERS 2023

Benralizumab may still lead to remission even in second year of treatment

MedNet.nl: One-quarter to one-third of patients with severe eosinophilic asthma who do not achieve clinical remission after 1 year of treatment with benralizumab still achieve remission in the second year of treatment. In patients who do achieve remission in the first year, over three-quarters maintain remission in the second year as well.

Related topics

A quick guide to ECGs

Electrocardiography Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

Obesity Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more